dengu
estim
infect
million
individu
annual
make
preval
arthropodborn
viral
diseas
world
viru
classifi
four
relat
distinct
serotyp
transmit
human
primarili
mosquito
aed
aegypti
case
asymptomat
diseas
symptom
occur
approxim
one
quarter
dengu
infect
rang
sever
breakbon
dengu
fever
df
lifethreaten
dengu
haemorrhag
fever
dhf
character
vascular
plasma
leakag
may
lead
circulatori
shock
known
dengu
shock
syndrom
dss
sever
clinic
manifest
dengu
prompt
numer
studi
aim
improv
understand
dengu
pathogenesi
role
immun
respons
play
control
viral
infect
experiment
studi
mice
shown
innat
immun
respons
import
clear
primari
dengu
infect
wherea
adapt
immun
respons
contribut
develop
sever
diseas
studi
shown
human
dengu
antibodi
enhanc
viral
growth
vitro
therebi
increas
risk
develop
sever
diseas
secondari
infect
heterolog
serotyp
studi
shown
memori
tcell
establish
primari
infect
may
act
increas
risk
develop
sever
diseas
heterolog
secondari
infect
increas
proinflammatori
cytokin
product
complement
experiment
studi
epidemiolog
studi
success
isol
host
viral
risk
factor
associ
sever
diseas
taken
togeth
studi
indic
excess
activ
immun
respons
dengu
infect
may
lead
cascad
cytokin
product
known
cytokin
storm
result
direct
damag
vascular
endotheli
cell
increas
capillari
permeabl
cytokin
storm
phenomenon
uniqu
dengu
also
use
describ
patholog
result
viral
infect
includ
influenza
cytomegaloviru
sever
acut
respiratori
syndrom
coronaviru
apart
experiment
studi
viral
pathogen
mathemat
model
describ
infect
dynam
within
host
provid
addit
insight
viral
kinet
diseas
outcom
model
larg
part
focus
chronic
infecti
diseas
human
immunodefici
viru
hiv
hepat
c
viru
diseas
caus
acut
infect
influenza
extens
studi
pathogen
date
probabl
due
avail
human
nonhuman
anim
challeng
studi
data
influenza
model
highlight
import
innat
adapt
immun
respons
regul
viral
dynam
particularli
role
innat
immun
respons
contribut
diseas
symptom
dengu
awar
four
exist
withinhost
model
three
model
consid
dynam
interact
free
viru
uninfect
target
cell
infect
target
cell
immun
cell
differ
one
anoth
function
form
use
model
viral
infect
viral
clearanc
immun
cell
dynam
three
model
immun
cell
play
protect
role
clear
infect
cell
therefor
like
repres
cell
none
model
consid
known
effect
cell
gener
adapt
immun
respons
may
contribut
dengu
diseas
note
one
model
statist
fit
individuallevel
patient
data
find
indic
differ
viral
dynam
primari
secondari
infect
recov
higher
viral
infect
rate
secondari
infect
result
consist
evid
enhanc
viral
infect
result
increas
level
nonneutr
antibodi
secondari
infect
rel
primari
infect
fourth
model
consid
dynam
interact
free
viru
uninfect
cell
infect
cell
b
cell
antibodi
model
effect
antibodi
either
protect
enhanc
depend
antigen
similar
viru
primari
infect
viru
secondari
infect
howev
model
provid
explicit
mechan
diseas
aris
instead
assum
diseas
sever
posit
correl
level
antibodi
heterolog
secondari
infect
none
exist
dengu
model
consid
role
innat
immun
respons
play
control
viral
infect
infect
dynam
explicitli
impact
diseas
sever
aim
develop
minim
withinhost
mathemat
model
dengu
infect
abl
recov
known
featur
primari
secondari
dengu
infect
use
basi
understand
character
pattern
diseas
sever
approach
thu
analys
model
increas
complex
evalu
model
dynam
featur
yield
begin
simpl
target
cell
limit
model
stepwis
fashion
consid
dynam
effect
innat
adapt
immun
respons
contribut
dengu
infect
dynam
first
parametr
consid
model
primari
symptomat
infect
use
combin
literatur
estim
clinic
observ
serv
constraint
model
paramet
show
innat
immun
respons
need
recov
characterist
featur
primari
infect
arriv
minim
model
secondari
dengu
infect
build
minim
primari
infect
model
recov
characterist
featur
secondari
infect
differ
primari
infect
find
higher
viral
infect
rate
along
infect
cell
clearanc
cell
necessari
reproduc
characterist
featur
secondari
dengu
infect
underscor
contribut
adapt
immun
respons
infect
show
minim
dengu
model
select
analysi
yield
viral
dynam
consist
recent
publish
individu
viral
load
data
dengu
establish
higher
viral
load
associ
sever
diseas
discord
dengu
literatur
whether
cellular
immun
respons
protect
facilit
onset
sever
diseas
risk
develop
sever
diseas
depend
circul
cytokin
level
develop
two
diseas
sever
parametr
differ
contribut
tcellsecret
cytokin
diseas
sever
discrimin
differ
formul
examin
relationship
known
virolog
indic
diseas
sever
isol
clinic
literatur
risk
develop
sever
diseas
model
present
first
best
knowledg
quantit
describ
interact
immun
system
dengu
viru
lead
increas
cytokin
product
therebi
increas
risk
manifest
sever
diseas
analysi
virolog
indic
diseas
sever
provid
insight
infect
cell
cell
may
contribut
diseas
sever
furthermor
analysi
highlight
effect
virolog
indic
predict
dengu
diseas
sever
critic
depend
contribut
cell
diseas
sever
viral
kinet
data
dengu
patient
often
absent
prior
fever
onset
eg
comprehens
studi
cytokin
human
infect
similarli
miss
taken
even
singl
time
point
postinfect
furthermor
consider
variat
among
studi
cytokin
level
potenti
due
rel
short
halfliv
instead
evalu
differ
mathemat
model
directli
fit
incomplet
avail
data
first
develop
minim
model
primari
dengu
infect
abl
reproduc
wellestablish
characterist
featur
viral
infect
primari
dengu
infect
result
df
featur
target
cell
monocyt
deplet
approxim
origin
level
dengu
infect
approx
cell
cell
ii
peak
viraemia
occur
approxim
day
post
viral
inocul
base
estim
incub
period
time
peak
viraemia
onset
symptom
iii
maximum
daili
clearanc
rate
approxim
copi
per
millilitr
per
day
iv
peak
viraemia
approxim
copi
per
millilitr
latter
two
featur
measur
patient
may
perfectli
reflect
characterist
featur
dengu
serotyp
begin
examin
target
cell
limit
model
conceiv
simplest
withinhost
model
formul
model
previous
use
model
acut
influenza
infect
given
suscept
cell
deplet
becom
infect
free
viru
v
rate
free
viru
produc
infect
cell
rate
pi
clear
rate
cv
infect
cell
die
rate
reduc
system
equat
two
dimens
assum
consist
empir
find
dynam
viru
fast
rel
dynam
infect
cell
quasisteadyst
assumpt
equat
becom
v
pc
given
expect
maxim
copi
per
millilitr
daili
declin
viral
clearanc
third
characterist
featur
list
calcul
minimum
need
achiev
viral
declin
assum
short
time
interv
viral
peak
assumpt
also
use
approxim
viral
declin
rate
viral
peak
assumpt
didt
use
approxim
v
v
v
achiev
viral
declin
minimum
need
per
day
determin
whether
estim
biolog
reason
first
note
dengu
viru
life
cycl
result
exocytosi
matur
infecti
particl
infect
cell
therefor
result
burst
infect
cell
dengu
viru
also
shown
abl
manipul
antivir
respons
result
delay
prevent
host
cell
death
therefor
assum
lifespan
infect
cell
similar
uninfect
monocyt
vivo
lifespan
estim
rang
one
two
month
minimum
estim
yield
lifespan
estim
day
two
order
magnitud
shorter
valu
suggest
must
process
besid
background
infect
cell
mortal
respons
viral
declin
dengu
infect
simpl
analysi
indic
target
cell
limit
model
unlik
abl
reproduc
characterist
featur
primari
dengu
infect
biolog
reason
paramet
valu
also
perform
systemat
analysi
determin
model
abil
jointli
reproduc
first
three
character
featur
primari
dengu
infect
list
includ
fourth
characterist
featur
peak
viral
load
trivial
reproduc
assumpt
fast
viral
dynam
set
initi
number
suscept
cell
cell
base
absolut
count
monocyt
green
et
al
model
contain
three
free
paramet
initi
number
infect
cell
infect
cell
clearanc
rate
paramet
combin
fix
valu
first
examin
whether
valu
could
jointli
recov
three
character
featur
primari
dengu
infect
figur
figur
show
biolog
reason
estim
per
day
correspond
approxim
lifespan
month
valu
model
abl
recov
three
character
featur
primari
dengu
infect
unrealist
high
valu
per
day
howev
target
cell
model
abl
recov
character
featur
primari
dengu
infect
figur
result
indic
simpl
model
extend
incorpor
process
aid
infect
cell
clearanc
could
principl
suffic
reproduc
key
featur
primari
dengu
infect
biolog
realist
paramet
valu
overal
result
robust
chang
initi
number
infect
cell
impact
time
peak
viraemia
minim
impact
two
viral
dynam
featur
given
insuffici
target
cell
limit
model
turn
toward
examin
complex
withinhost
model
specif
includ
innat
immun
respons
type
interferon
ifn
shown
import
inhibit
viral
replic
modul
downstream
effect
immun
respons
well
activ
natur
killer
nk
cell
play
import
role
lyse
virusinfect
cell
specif
context
dengu
type
ifn
level
shown
elev
earli
infect
similarli
earli
activ
nk
cell
demonstr
dengu
patient
studi
suggest
compon
innat
immun
respons
may
play
import
role
inhibit
dengu
viru
replic
model
effect
innat
immun
respons
dengu
viral
kinet
therefor
start
consid
effect
ifn
nk
cell
recent
publish
influenza
model
model
make
simplifi
assumpt
circul
nk
cell
proport
level
circul
ifn
assumpt
innat
immun
respons
model
given
ifn
f
produc
infect
cell
decay
rate
nk
cell
lyse
infect
cell
rate
proport
ifn
known
short
halflif
reduc
dimension
model
assum
fast
dynam
f
quasisteadyst
assumpt
equat
becom
v
f
qd
quasisteadyst
assumpt
free
viru
ifn
level
result
expect
linear
relationship
v
f
consist
relationship
observ
hospit
df
patient
experienc
primari
infect
assum
per
day
equat
two
free
paramet
combin
qd
well
initi
condit
given
valu
analys
effect
paramet
combin
first
three
character
model
featur
describ
figur
case
target
cell
limit
model
peak
viraemia
level
trivial
reproduc
consid
fourth
featur
model
simultan
recov
final
fraction
uninfect
cell
figur
time
peak
viraemia
figur
howev
simultan
reproduc
known
daili
viral
clearanc
rate
figur
along
two
featur
fact
model
recov
daili
viral
clearanc
rate
copi
combin
qd
due
nonlinear
introduc
term
nonlinear
viral
declin
scale
result
term
also
inconsist
sever
viral
kinet
studi
show
viral
clearanc
larg
linear
log
scale
find
indic
equat
jointli
reproduc
featur
primari
dengu
infect
target
cell
limit
model
chang
initi
number
infect
cell
chang
result
chang
substanti
impact
time
peak
viraemia
character
model
featur
also
consid
complex
model
ifn
ifn
secret
accord
nonlinear
satur
term
qi
k
decay
rate
df
see
electron
supplementari
materi
model
abl
recov
characterist
featur
primari
dengu
infect
includ
unneed
complex
due
five
free
paramet
abl
reproduc
viral
clearanc
rate
ifn
decay
late
infect
postdefervesc
declin
ifn
inconsist
ifn
kinet
studi
equat
unabl
jointli
recov
characterist
featur
primari
dengu
infect
complic
model
consid
electron
supplementari
materi
could
reproduc
characterist
featur
biolog
implaus
ifn
dynam
next
consid
whether
model
nk
cell
explicitli
would
provid
suffici
minim
model
relax
fast
nkcell
dynam
assumpt
natur
next
step
increas
model
complex
vivo
model
studi
human
nkcell
dynam
viral
infect
suggest
nk
cell
slow
decay
rate
thu
ifn
dynam
repres
nk
dynam
furthermor
studi
dengueinfect
patient
show
nkcell
activ
marker
elev
day
defervesc
time
point
level
known
alreadi
return
low
level
suggest
nk
cell
decay
slower
rate
ifn
therefor
assum
nk
cell
activ
rate
proport
ifn
qnf
decay
rate
dnn
assumpt
model
given
v
f
qd
assum
base
assum
nk
cell
halflif
day
correspond
valu
dn
per
day
model
three
free
paramet
combin
qn
qd
one
free
initi
condit
figur
show
chang
impact
model
featur
assum
given
valu
qn
qd
figur
indic
model
explicitli
includ
dynam
nk
cell
abl
recov
characterist
featur
primari
dengu
infect
chang
qn
qd
similar
effect
characterist
viral
featur
chang
affect
time
peak
viraemia
figur
show
dynam
uninfect
cell
infect
cell
free
viru
nk
cell
model
parametr
simultan
reproduc
three
featur
examin
figur
well
fourth
featur
peak
viraemia
tabl
provid
specif
paramet
valu
use
note
model
recent
publish
clapham
et
al
also
reproduc
characterist
featur
primari
infect
model
assum
immun
respons
prolifer
respons
interact
infect
cell
present
low
level
start
infect
act
kill
infect
cell
although
author
explicitli
interpret
model
one
model
cellular
immun
respons
immun
respons
formul
close
mirror
previou
model
descript
cell
contrari
assumpt
experiment
studi
mice
shown
cell
critic
clearanc
dengu
viru
primari
infect
though
relev
mous
model
understand
human
dengu
infect
question
given
low
replic
abil
dengu
mice
studi
tcell
respons
human
primari
dengu
infect
howev
appear
support
conclus
reach
mous
studi
cell
activ
larg
quantiti
earli
infect
henc
cell
unlik
play
larg
role
clear
dengu
viru
primari
infect
sinc
studi
support
role
innat
immun
respons
adapt
immun
respons
clear
primari
dengu
infect
consid
nk
model
equat
minim
primari
infect
model
dynam
secondari
dengu
infect
differ
markedli
primari
dengu
infect
seek
develop
minim
model
capabl
reproduc
characterist
featur
secondari
infect
rel
primari
dengu
infect
secondari
dengu
infect
encompass
symptomat
clinic
manifest
character
shorter
time
peak
viraemia
ii
higher
maximum
viral
clearanc
rate
approx
copi
per
millilitr
per
day
df
copi
per
millilitr
per
day
dhf
iii
higher
peak
viraemia
includ
featur
final
fraction
uninfect
cell
dynam
uninfect
cell
secondari
infect
well
character
also
attempt
quantifi
specif
valu
peak
viraemia
time
peak
viraemia
viraemia
level
patient
secondari
dengu
infect
gener
alreadi
declin
time
patient
admit
first
sought
determin
whether
minim
model
capabl
reproduc
featur
primari
dengu
infect
could
reproduc
featur
secondari
dengu
infect
recov
secondari
infect
shorter
time
viral
peak
higher
level
peak
viraemia
increas
viral
infect
rate
suffici
result
peak
viraemia
level
viral
copi
day
post
viral
inocul
level
time
peak
viraemia
consist
virolog
data
secondari
df
dhf
patient
reparametr
also
easili
interpret
biolog
context
phenomenon
known
antibodydepend
enhanc
ade
propos
antibodi
first
infect
crossreact
viru
secondari
infect
lead
incomplet
neutral
result
partial
neutral
immun
complex
thought
enhanc
viral
entri
fcreceptor
bear
target
cell
result
increas
viral
infect
lead
higher
viraemia
increas
viral
infect
rate
could
reproduc
shorter
time
peak
viraemia
higher
level
peak
viraemia
chang
could
reproduc
higher
maximum
viral
clearanc
rate
least
copi
per
millilitr
per
day
motiv
current
understand
role
adapt
immun
system
play
secondari
dengu
infect
sought
determin
whether
extend
minim
model
implement
effect
cellular
immun
respons
would
suffici
reproduc
higher
viral
clearanc
rate
seen
secondari
infect
extens
model
becom
v
f
qd
model
assum
cell
recruit
rate
qtit
decay
rate
dtt
lyse
infect
cell
rate
substitut
model
equat
demonstr
estim
independ
therefor
set
examin
effect
chang
model
dynam
set
cell
sinc
cell
undergo
expans
primari
viral
infect
assum
lifespan
cell
day
model
paramet
primari
infect
model
except
increas
model
retain
two
free
paramet
tcell
recruit
rate
qt
rate
cell
lyse
infect
cell
figur
show
two
paramet
combin
affect
featur
secondari
dengu
infect
paramet
neglig
effect
peak
viraemia
valu
figur
time
peak
viraemia
figur
cell
circul
high
level
peak
viraemia
howev
higher
valu
qt
result
higher
viral
clearanc
rate
figur
chang
mirror
influenc
viral
clearanc
rate
littl
effect
peak
viraemia
valu
time
peak
viraemia
result
indic
three
featur
secondari
infect
recov
reparametr
viral
infect
rate
primari
infect
dengu
model
reflect
effect
humor
immun
respons
along
explicit
incorpor
cellular
immun
respons
figur
show
dynam
model
rel
model
dynam
primari
dengu
infect
paramet
valu
simul
provid
tabl
intriguingli
result
consist
recent
statist
find
clapham
et
al
indic
secondari
dengu
infect
higher
estim
viral
infect
rate
higher
viral
clearanc
rate
primari
dengu
infect
individuallevel
dengu
viral
load
data
recent
made
avail
allow
us
compar
model
simul
dengu
patient
data
data
come
clinic
trial
adult
dengu
patient
hospit
tropic
diseas
ho
chi
minh
citi
vietnam
viraemia
measur
blood
twice
day
follow
hospit
arriv
within
h
report
symptom
onset
viru
quantifi
rtpcr
assum
incub
period
viral
inocul
onset
symptom
day
figur
show
viral
load
kinet
simul
use
minim
primari
secondari
infect
model
parametr
provid
tabl
along
data
df
dhf
primari
secondari
dengu
infect
though
consider
variabl
observ
data
model
simul
effect
captur
gener
dynam
furthermor
data
shown
consist
featur
describ
dengu
viral
load
data
contain
noninfecti
infecti
viral
particl
howev
consid
infecti
viru
model
without
impact
model
variabl
introduc
convers
factor
captur
ratio
viru
particl
infecti
viru
particl
divid
model
paramet
convers
factor
multipli
paramet
factor
dynam
system
remain
unchang
except
free
viru
dynam
dynam
chang
v
proport
reduc
magnitud
factor
time
point
therebi
model
infecti
viru
particl
instead
viru
particl
dhfdss
character
increas
vascular
leakag
mani
studi
examin
relationship
proinflammatori
cytokin
enhanc
capillari
permeabl
risk
develop
sever
diseas
vascular
leakag
hallmark
dhf
occur
around
time
defervesc
last
approxim
h
period
level
consist
seen
elev
dhf
patient
compar
df
patient
healthi
control
particular
shown
correl
diseas
sever
numer
studi
furthermor
human
polymorph
predispos
high
product
shown
associ
increas
suscept
dhf
work
synergist
mediat
activ
endotheli
cell
although
complet
role
cytokin
play
dengu
pathogenesi
clear
peak
level
shown
strongli
correl
diseas
sever
mechan
result
high
cytokin
product
complex
probabl
multifactori
mani
studi
shown
viraemia
level
consist
correl
diseas
sever
high
viraemia
caus
consequ
high
number
infect
cell
infect
cell
secret
cytokin
suggest
high
viraemia
reflect
high
number
infect
cell
necessari
develop
plasma
leakag
howev
high
viraemia
may
suffici
develop
plasma
leakag
tcellsecret
cytokin
also
implic
develop
sever
diseas
specif
theori
known
origin
antigen
sin
oa
propos
memori
tcell
popul
low
avid
infect
viru
heterolog
secondari
infect
caus
strong
proinflammatori
respons
would
memori
tcell
popul
activ
secondari
infect
yet
low
avid
abil
cell
lyse
infect
cell
therebi
protect
viral
infect
may
poor
support
oa
studi
dengu
virusspecif
tcell
respons
thai
children
show
major
dengu
virusspecif
cell
low
affin
infect
serotyp
high
affin
one
three
serotyp
studi
also
show
patient
dss
stronger
tcell
respons
individu
less
sever
diseas
contrast
patholog
effect
cell
recent
studi
suggest
cell
may
instead
play
protect
role
sever
diseas
specif
weiskopf
et
al
show
individu
strong
tcell
respons
associ
hla
allel
appear
confer
protect
sever
diseas
show
transgen
mice
heterolog
secondari
infect
respons
direct
serotypespecif
epitop
impair
respons
conserv
epitop
suggest
heterolog
secondari
infect
associ
limit
tcell
respons
dung
et
al
document
tempor
mismatch
tcell
activ
vascular
leakag
suggest
tcellsecret
cytokin
contribut
develop
sever
diseas
taken
togeth
studi
show
infect
cell
cell
known
secret
cytokin
associ
sever
diseas
contribut
tcell
produc
cytokin
sever
diseas
unclear
determin
whether
minim
model
develop
primari
secondari
dengu
infect
abl
recov
wellestablish
pattern
increas
risk
sever
diseas
heterolog
secondari
infect
consid
diseas
sever
formul
two
differ
parametr
first
parametr
assum
tcellsecret
cytokin
impact
develop
sever
diseas
wherea
second
assum
cell
may
act
exacerb
diseas
sever
although
alon
precipit
sever
diseas
keep
model
simpl
possibl
group
endotheli
cell
activ
cytokin
singl
variabl
e
assum
cytokin
primarili
secret
infect
cell
rate
qei
decay
rate
dee
includ
possibl
patholog
role
cell
assum
tcellsecret
cytokin
amplifi
proinflammatori
respons
orchestr
signal
infect
cell
suggest
dung
et
al
peak
level
endotheli
cell
activ
cytokin
shown
strongli
correl
diseas
sever
assum
risk
develop
sever
diseas
proport
peak
level
e
diseas
sever
max
e
mathemat
dynam
diseaseassoci
cytokin
therefor
given
tcellsecret
cytokin
contribut
diseas
sever
wherea
cytokin
exacerb
diseas
sever
figur
show
diseas
sever
parametr
secondari
heterolog
infect
result
higher
peak
valu
endotheli
activ
compar
primari
dengu
infect
therefor
parametr
result
higher
risk
develop
sever
diseas
compar
primari
infect
first
virolog
indic
diseas
sever
consid
peak
viraemia
higher
magnitud
viral
load
earli
infect
repeatedli
associ
higher
risk
develop
sever
diseas
viral
peak
observ
higher
valu
peak
viraemia
associ
higher
risk
develop
sever
diseas
figur
show
model
reproduc
observ
posit
associ
peak
viral
load
peak
endotheli
cell
activ
level
furthermor
figur
show
secondari
infect
peak
viral
load
peak
e
level
indic
risk
develop
sever
diseas
gener
higher
primari
infect
assum
tcellsecret
cytokin
contribut
diseas
sever
secondari
infect
similar
peak
viraemia
valu
primari
infect
nevertheless
carri
higher
peak
level
endotheli
activ
despit
show
clear
posit
relationship
peak
viral
load
peak
level
endotheli
activ
figur
also
indic
relationship
perfect
scatter
qualit
understand
scatter
level
peak
viraemia
peak
level
endotheli
activ
examin
direct
effect
vari
paramet
primari
dengu
infect
secondari
dengu
infect
diseas
sever
assum
due
infect
cellsecret
cytokin
level
peak
viraemia
almost
perfect
predictor
diseas
sever
figur
increas
earli
act
paramet
act
increas
number
infect
cell
result
higher
peak
viraemia
higher
maximum
number
endotheli
activ
increas
lateact
paramet
qn
qd
dn
qt
dt
act
decreas
number
infect
cell
result
lower
peak
viraemia
lower
maximum
number
endotheli
activ
secondari
dengu
infect
assum
tcellsecret
cytokin
contribut
diseas
sever
see
scatter
relationship
peak
viraemia
peak
level
e
variat
paramet
affect
tcell
dynam
dispar
direct
effect
specif
paramet
chang
increas
tcell
level
lower
peak
viraemia
increas
peak
level
e
analysi
suggest
peak
viraemia
rel
good
indic
diseas
sever
also
highlight
cell
contribut
significantli
cytokin
storm
predict
indic
limit
second
indic
diseas
sever
consid
time
peak
viraemia
sever
studi
shown
high
viraemia
level
earli
infect
associ
higher
risk
develop
sever
diseas
primari
infect
shorter
time
peak
viraemia
associ
higher
diseas
sever
peak
viraemia
rare
observ
secondari
infect
suggest
viru
peak
earlier
secondari
infect
rel
primari
infect
figur
show
model
recov
describ
neg
relationship
time
peak
viraemia
peak
level
endotheli
activ
secondari
infect
assum
cell
contribut
diseas
sever
given
time
peak
viraemia
result
substanti
higher
peak
level
endotheli
activ
compar
cell
play
protect
role
relationship
time
peak
viraemia
peak
level
endotheli
activ
display
consider
scatter
observ
peak
viraemia
peak
level
endotheli
activ
figur
versu
lateact
paramet
qn
qd
dn
qt
dt
significantli
impact
time
peak
viraemia
valu
consider
impact
peak
endotheli
activ
level
increas
scatter
present
tcellsecret
cytokin
contribut
level
endotheli
activ
number
cell
impact
peak
level
endotheli
activ
essenti
effect
time
peak
viraemia
analysi
suggest
time
peak
viraemia
may
limit
use
virolog
indic
diseas
sever
consider
variat
immun
respons
individu
cell
contribut
diseas
sever
time
peak
viraemia
becom
even
less
effect
indic
diseas
sever
hand
individu
variabl
larg
domin
earli
act
paramet
would
expect
time
peak
viraemia
effect
indic
studi
shown
conflict
associ
rate
viral
clearanc
risk
develop
sever
diseas
wang
colleagu
exampl
found
lower
viral
clearanc
rate
associ
develop
dhf
studi
individu
experienc
secondari
dengu
infect
contrast
vaughn
et
al
found
higher
viral
clearanc
rate
associ
develop
dhf
studi
individu
experienc
either
primari
secondari
infect
latter
studi
show
viral
clearanc
rate
significantli
higher
secondari
dengu
infect
primari
dengu
infect
similarli
third
studi
individu
experienc
either
primari
secondari
infect
found
higher
rate
viral
clearanc
secondari
dengu
infect
primari
dengu
infect
along
slightli
lower
rate
viral
clearanc
patient
dhf
secondari
infect
compar
df
figur
show
model
predict
posit
relationship
rate
viral
clearanc
quantifi
maxim
daili
viral
clearanc
rate
peak
level
endotheli
activ
primari
secondari
infect
assum
tcellsecret
cytokin
contribut
diseas
sever
given
viral
clearanc
rate
result
substanti
higher
peak
level
endotheli
activ
compar
cell
play
protect
role
consider
scatter
relationship
viral
clearanc
rate
peak
level
endotheli
activ
chang
paramet
affect
nk
tcell
dynam
opposit
effect
viral
clearanc
rate
level
endotheli
activ
paramet
chang
increas
number
nk
cell
cell
simultan
increas
viral
clearanc
rate
decreas
number
infect
cell
therewith
peak
endotheli
activ
level
find
indic
viral
clearanc
rate
may
good
indic
predict
onset
sever
diseas
help
understand
conflict
result
studi
describ
result
wang
et
al
show
lower
viral
clearanc
rate
associ
increas
diseas
sever
suggest
cell
patient
play
larg
protect
role
low
clearanc
rate
reflect
suboptim
tcell
respons
opposit
result
observ
two
studi
may
explain
interindividu
variat
earli
act
paramet
cell
contribut
diseas
sever
strong
tcell
respons
electron
supplementari
materi
consid
whether
result
shown
figur
robust
altern
diseas
sever
formul
one
altern
formul
reflect
assumpt
cell
secret
cytokin
contribut
diseas
sever
secret
cytokin
simpli
amplifi
contribut
addit
peak
e
level
assumpt
lead
altern
diseas
sever
formul
dedt
qei
dee
instead
equat
paramet
quantifi
product
rate
endotheli
activ
cell
formul
reproduc
relationship
virolog
indic
peak
level
e
observ
origin
diseas
sever
formul
provid
equat
electron
supplementari
materi
figur
altern
formul
howev
individu
high
tcell
count
low
viraemia
experi
high
risk
develop
sever
diseas
pattern
support
literatur
return
equat
describ
endotheli
activ
dynam
altern
consid
risk
sever
diseas
proport
total
amount
endotheli
activ
secret
infect
altern
formul
also
reproduc
describ
relationship
virolog
indic
risk
develop
sever
diseas
electron
supplementari
materi
figur
howev
diseas
measur
incorpor
cytokin
dynam
vascular
leakag
occur
make
degre
biolog
unreason
incorpor
postdefervesc
cytokin
dynam
also
gener
scatter
relationship
virolog
indic
risk
develop
sever
diseas
develop
suit
withinhost
mathemat
withinhost
dengu
model
describ
dynam
viru
better
understand
develop
sever
dengu
diseas
first
begin
target
cell
model
ad
increas
complex
arriv
minim
model
abl
reproduc
character
viral
featur
primari
secondari
infect
shown
innat
immun
respons
need
recov
featur
primari
dengu
infect
secondari
dengu
infect
higher
rate
viral
infect
repres
ade
need
recov
higher
peak
viraemia
valu
shorter
time
peak
viraemia
cell
need
recov
higher
viral
clearanc
rate
parametr
minim
model
use
combin
literatur
estim
describ
featur
model
first
dengu
model
link
withinhost
dynam
quantit
measur
diseas
sever
specif
assum
sever
dengu
diseas
character
vascular
leakag
result
cytokin
storm
consist
current
think
develop
two
diseas
sever
formul
differ
contribut
tcellsecret
cytokin
diseas
sever
diseas
sever
formul
greatli
simplifi
complex
mechan
lead
sever
dengu
diseas
first
step
provid
quantit
framework
understand
process
jointli
regul
viral
dynam
drive
onset
sever
diseas
shown
simul
model
reproduc
associ
relationship
known
virolog
indic
peak
level
endotheli
activ
measur
risk
develop
sever
diseas
relationship
robust
diseas
sever
parametr
howev
also
shown
effect
indic
depend
heavili
yet
disput
contribut
cell
precipit
sever
diseas
although
model
reproduc
viral
pattern
associ
known
virolog
indic
risk
develop
sever
diseas
current
parametr
model
obtain
statist
fit
data
instead
parametr
base
wellestablish
viral
featur
statist
fit
data
perform
clapham
et
al
extrem
valuabl
lack
avail
viral
immunolog
data
earli
dengu
infect
current
limit
factor
robustli
estim
model
paramet
underscor
import
larg
longitudin
cohort
studi
facilit
collect
type
data
pediatr
dengu
cohort
studi
nicaragua
exampl
routin
test
children
dengu
detect
inappar
well
symptomat
infect
type
studi
abl
obtain
detail
viral
measur
earli
infect
specif
viraemia
peak
along
viral
kinet
data
detail
kinet
data
nk
tcell
activ
marker
relat
time
vascular
leakag
hallmark
dhf
need
help
elucid
extent
protect
role
nk
cell
contribut
cell
diseas
sever
addit
detail
kinet
studi
cytokin
relat
time
vascular
leakag
use
determin
cytokin
best
marker
diseas
sever
parametr
model
focus
exclus
differ
primari
secondari
dengu
infect
howev
well
known
risk
develop
sever
diseas
secondari
dengu
infect
depend
ident
particular
viru
serotyp
primari
infect
well
viru
serotyp
secondari
infect
secondari
infect
model
suffici
flexibl
abl
examin
orderofinfect
effect
simpli
reparametr
thorough
analysi
howev
critic
depend
data
avail
current
unawar
studi
examin
viral
load
dynam
individu
experienc
secondari
dengu
infect
serotyp
ident
primari
infect
document
also
explicitli
address
temporari
crossprotect
crossimmun
serotyp
model
although
observ
epidemiolog
studi
indic
individu
protect
either
infect
diseas
year
follow
primari
infect
model
howev
could
easili
accommod
effect
reparametr
presum
individu
protect
heterolog
secondari
infect
period
follow
primari
infect
protect
antibodi
level
remain
suffici
high
capabl
effect
neutral
viru
model
would
lead
increas
viral
clearanc
rate
lower
withinhost
basic
reproduct
number
decreas
basic
reproduct
number
result
either
inabl
viru
infect
individu
reduc
viraemia
simpl
reparametr
model
indic
expect
see
lower
risk
develop
sever
diseas
recent
infect
individu
altern
parametr
use
consid
certain
question
examin
model
make
sever
simplifi
assumpt
need
relax
address
outstand
question
first
secondari
infect
model
assum
humor
immun
respons
occur
immedi
stay
constant
level
repres
increas
current
model
explicitli
includ
dynam
humor
immun
respons
may
oversimplifi
contribut
antibodi
diseas
sever
furthermor
dynam
adapt
immun
respons
need
model
understand
exampl
downstream
effect
antibodi
respons
modul
cytokin
product
intrins
ade
second
simplic
distinguish
differ
type
cytokin
therefor
includ
role
certain
cytokin
upregul
downregul
product
cytokin
may
import
understand
complex
mechan
lead
occurr
vascular
leakag
although
assumpt
withinhost
mathemat
model
current
make
limit
applic
certain
question
believ
stand
good
jump
point
complex
model
first
attempt
understand
dynam
dengu
viru
immunolog
respons
host
affect
risk
develop
sever
diseas
provid
insight
contribut
infect
cell
cell
diseas
sever
highlight
import
withinhost
dynam
earli
infect
predict
diseas
sever
also
highlight
predict
virolog
indic
depend
understand
mechan
lead
sever
diseas
modif
model
term
parametr
structur
requir
extens
dataset
critic
continu
collabor
interact
quantit
biologist
dengu
virologist
immunologist
